HRP20120147T1 - Titracija tapentadola - Google Patents

Titracija tapentadola Download PDF

Info

Publication number
HRP20120147T1
HRP20120147T1 HR20120147T HRP20120147T HRP20120147T1 HR P20120147 T1 HRP20120147 T1 HR P20120147T1 HR 20120147 T HR20120147 T HR 20120147T HR P20120147 T HRP20120147 T HR P20120147T HR P20120147 T1 HRP20120147 T1 HR P20120147T1
Authority
HR
Croatia
Prior art keywords
dose
tapentadol
administration
administration interval
interval
Prior art date
Application number
HR20120147T
Other languages
English (en)
Croatian (hr)
Inventor
Lange Claudia
Rombout Ferdinand
Original Assignee
Grnenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20120147(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grnenthal Gmbh filed Critical Grnenthal Gmbh
Publication of HRP20120147T1 publication Critical patent/HRP20120147T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20120147T 2007-04-23 2008-04-21 Titracija tapentadola HRP20120147T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (fr) 2007-04-23 2007-04-23 Titrage de tapentadol
PCT/EP2008/003178 WO2008128740A1 (fr) 2007-04-23 2008-04-21 Titration du tapentadol

Publications (1)

Publication Number Publication Date
HRP20120147T1 true HRP20120147T1 (hr) 2012-03-31

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120147T HRP20120147T1 (hr) 2007-04-23 2008-04-21 Titracija tapentadola

Country Status (21)

Country Link
US (4) US20090012180A1 (fr)
EP (5) EP1985292A1 (fr)
JP (4) JP5933176B2 (fr)
KR (3) KR20100017267A (fr)
CN (1) CN101730530B (fr)
AT (1) ATE534378T1 (fr)
AU (1) AU2008241013B2 (fr)
CA (1) CA2683786C (fr)
CY (1) CY1112320T1 (fr)
DK (1) DK2148670T3 (fr)
ES (1) ES2378255T3 (fr)
HR (1) HRP20120147T1 (fr)
IL (1) IL201479A (fr)
MX (1) MX2009011444A (fr)
NZ (1) NZ580415A (fr)
PL (1) PL2148670T3 (fr)
PT (1) PT2148670E (fr)
RU (1) RU2472497C2 (fr)
SI (1) SI2148670T1 (fr)
WO (1) WO2008128740A1 (fr)
ZA (1) ZA200907355B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (fr) * 2007-04-23 2008-10-29 Grünenthal GmbH Titrage de tapentadol
BRPI0921725A2 (pt) * 2008-10-30 2016-01-05 Grüenthal GmbH formas de dosagem potentes do tapentadol
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2566461A2 (fr) * 2010-05-05 2013-03-13 Ratiopharm GmbH Tapentadol solide sous forme non cristalline
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
PL2588093T3 (pl) * 2010-06-30 2017-07-31 Grünenthal GmbH Tapentadol do zastosowania w leczeniu zespołu jelita drażliwego
EP3597628A1 (fr) * 2010-07-23 2020-01-22 Grünenthal GmbH Sels ou co-cristaux de 3-(3-dimethylamino-1-éthyl-2-méthyl-propyl)-phénol
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
CA2828635C (fr) * 2011-03-04 2020-01-14 Grunenthal Gmbh Administration parenterale de tapentadol
KR101946790B1 (ko) 2011-03-04 2019-02-13 그뤼넨탈 게엠베하 경구 투여를 위한 타펜타돌의 수성 약제학적 제형
RS56692B1 (sr) 2011-03-04 2018-03-30 Gruenenthal Gmbh Polučvrsta vodena farmaceutska kompozicija koja sadrži tapentadol
US20120309840A1 (en) * 2011-04-05 2012-12-06 Gruenenthal Gmbh Treatment of Pain Associated with Trigeminal Neuralgia
RS58064B1 (sr) 2011-04-05 2019-02-28 Gruenenthal Gmbh Tapentadol za sprečavanje hronifikacije bola
LT3272343T (lt) 2011-04-29 2020-05-11 Grünenthal GmbH Tapentadolis, skirtas depresijos ir nerimo prevencijai ir gydymui
ES2681952T3 (es) * 2013-03-15 2018-09-17 SpecGx LLC Forma farmacéutica sólida disuasoria del abuso de liberación inmediata con puntaje funcional
EP2845625A1 (fr) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol pour utilisation dans le traitement de la fibromyalgie et du syndrome de fatigue chronique
EP3273953B1 (fr) 2015-03-27 2019-01-02 Grünenthal GmbH Formulation stable pour l'administration parenterale de tapentadol
ES2869981T3 (es) * 2015-05-26 2021-10-26 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Composiciones para su uso en el tratamiento de la enfermedad de parkinson y trastornos relacionados
JP7373904B2 (ja) * 2016-02-29 2023-11-06 パーク・セラピューティクス・インコーポレイテッド セブラノパドールの滴定
CN109996533A (zh) 2016-09-23 2019-07-09 格吕伦塔尔有限公司 用于肠胃外施用他喷他多的稳定制剂
ES3010208T3 (en) 2020-03-16 2025-04-01 Gruenenthal Gmbh Scored tablet comprising tapentadol
WO2022194941A1 (fr) * 2021-03-17 2022-09-22 Actelion Pharmaceuticals Ltd Système de dosage pharmaceutique
WO2022234076A1 (fr) * 2021-05-07 2022-11-10 Grünenthal GmbH Tapentadol utilisé dans le traitement de la douleur neuropathique chez des patients âgés

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
AU2003297073A1 (en) 2002-12-13 2004-07-09 Euro-Celtique S.A. Transdermal buprenorphine dosage regimen for analgesia
US7413749B2 (en) 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1985292A1 (fr) 2007-04-23 2008-10-29 Grünenthal GmbH Titrage de tapentadol
DE102007019417A1 (de) * 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose

Also Published As

Publication number Publication date
CY1112320T1 (el) 2015-12-09
ZA200907355B (en) 2010-08-25
IL201479A (en) 2016-04-21
EP3143993A1 (fr) 2017-03-22
IL201479A0 (en) 2010-05-31
WO2008128740A1 (fr) 2008-10-30
PT2148670E (pt) 2012-01-24
JP2016128468A (ja) 2016-07-14
JP2018030864A (ja) 2018-03-01
EP2148670A1 (fr) 2010-02-03
AU2008241013A1 (en) 2008-10-30
DK2148670T3 (da) 2012-03-12
ATE534378T1 (de) 2011-12-15
EP2422778A1 (fr) 2012-02-29
US20090012180A1 (en) 2009-01-08
WO2008128740A8 (fr) 2010-06-17
US11344512B2 (en) 2022-05-31
KR20100017267A (ko) 2010-02-16
KR20150027840A (ko) 2015-03-12
HK1140940A1 (en) 2010-10-29
CN101730530A (zh) 2010-06-09
SI2148670T1 (sl) 2012-03-30
NZ580415A (en) 2012-04-27
PL2148670T3 (pl) 2012-04-30
US20170079938A1 (en) 2017-03-23
AU2008241013B2 (en) 2013-06-20
KR102078999B1 (ko) 2020-02-19
JP2010531296A (ja) 2010-09-24
EP3603630A1 (fr) 2020-02-05
US20160074342A1 (en) 2016-03-17
EP2148670B1 (fr) 2011-11-23
KR20180004839A (ko) 2018-01-12
JP5933176B2 (ja) 2016-06-08
ES2378255T3 (es) 2012-04-10
CN101730530B (zh) 2013-10-23
CA2683786A1 (fr) 2008-10-30
JP2019131598A (ja) 2019-08-08
RU2009142940A (ru) 2011-05-27
EP1985292A1 (fr) 2008-10-29
US20190290603A1 (en) 2019-09-26
CA2683786C (fr) 2021-10-26
RU2472497C2 (ru) 2013-01-20
MX2009011444A (es) 2009-11-05

Similar Documents

Publication Publication Date Title
HRP20120147T1 (hr) Titracija tapentadola
JP2021066744A5 (ja) ブプロピオンおよびデキストロメトルファンを含む組成物
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
JP2009102342A5 (fr)
CO6251259A2 (es) Formulaciones farmaceuticas de estriol en baja dosis
MX2008010155A (es) Composiciones virucidales que contienen metal y sus usos.
RU2015127794A (ru) Введение антисмысловых олигонуклеотидов, комплементарных человеческому аполипопротеину в
JP2012533554A5 (fr)
SI2501234T1 (en) Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
RU2007103306A (ru) Композиции на основе ризедроната и способы их применения
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
RU2487707C2 (ru) Применение парацетамола и ибупрофена в лечении
CA2570474A1 (fr) Compositions comprenant du paracetamol et de l'ibuprofene
HRP20130071T1 (hr) Poboljšani testosteron u gelu i naäśin primjene
HRP20090679T1 (hr) Upotreba oksikodona za liječenje organske boli
HRP20120228T1 (hr) Kladribinski režim za liječenje multiple skleroze
RU2008110933A (ru) Применение амброксола для лечения риновирусных инфекций
HRP20090256T1 (en) Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
NZ703464A (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
Chhina et al. Local Drug Delivery.
US20080045482A1 (en) Compositions and methods for the treatment of viral infections
MA27157A1 (fr) Methode de traitement d'affections osseuses.
AR066667A1 (es) Composiciones farmaceuticas que comrenden la combinacion de un agente derivado hidrogenado de lipstatina y un agente inhibidor de hmg coa reductasa